Healthcare -
Medical - Devices - NASDAQ - US
$ 1.3801
-4.82 %
$ 378 M
Market Cap
-0.87
P/E
Price Target
Average
117.38%
Revenue Forecast
Estimate
19.68%
EBIT
Estimate
11.11%
Net Income
Estimate
19.63%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pacific Biosciences of California, Inc.
Wall Street analysts predict an average 1-year price target for PACB of $3 , with forecasts ranging from
a
low of
$2 to a high of $4 .
PACB Lowest Price Target
Wall Street Target
2 USD
44.92%
PACB Average Price Target
Wall Street Target
3 USD
117.38%
PACB Highest Price Target
Wall Street Target
4 USD
189.83%
REVENUE FORECAST
Revenue Forecast Chart PACB
EBIT FORECAST
EBIT Forecast Chart PACB
NET INCOME FORECAST
Net Income Chart PACB